← Scoopfeeds — Intelligent news, curated.
Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance
business

Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance

Yahoo Finance · May 18, 2026, 12:32 PM · Also reported by 1 other source

Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance

Read full story on Yahoo Finance → More top stories

Also covered by

Bloomberg Markets Blue Owl Fund Returns to Market With $400 Million Bond Offering

More in business

Bloomberg Markets
The Shock Is Dead, Long Live the Shock!
CNBC
Kevin Warsh to be sworn in as Federal Reserve chair on Friday
Investing.com
FAA says it failed to address warning signals before fatal 2025 Washington D.C. collision
Investing.com
Why is Bajaj Finance stock climbing today?
Investing.com
Warsh to be sworn in as Fed chair at White House on Friday, Fox Business reports
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop